These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21304320)
41. Acute cholestatic hepatitis induced by Epstein-Barr virus infection in an adult: a case report. Khoo A J Med Case Rep; 2016 Mar; 10():75. PubMed ID: 27037083 [TBL] [Abstract][Full Text] [Related]
45. How best to manage chronic cholestasis. Grattagliano I; Floreani A; Ubaldi E; Portincasa P J Fam Pract; 2018 Jul; 67(7):E9-E15. PubMed ID: 29989620 [TBL] [Abstract][Full Text] [Related]
46. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Beuers U Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551 [TBL] [Abstract][Full Text] [Related]
47. Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject. Ader F; Chatellier D; Le Berre R; Morand P; Fourrier F Med Mal Infect; 2006 Jul; 36(7):396-8. PubMed ID: 16876362 [TBL] [Abstract][Full Text] [Related]
48. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. Stiehl A; Rudolph G; Sauer P; Theilmann L J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992 [TBL] [Abstract][Full Text] [Related]
49. [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)]. Masmoudi A; Hadj-Taieb I; Kammon T; Mseddi M; Boudaya S; Chaabouni M; Hachicha M; Turki H Ann Dermatol Venereol; 2008 Mar; 135(3):228-30. PubMed ID: 18374858 [No Abstract] [Full Text] [Related]
50. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis. Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845 [TBL] [Abstract][Full Text] [Related]
51. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard]. Stiefelhagen P MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736 [No Abstract] [Full Text] [Related]
52. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients. George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993 [TBL] [Abstract][Full Text] [Related]
53. [Lyell's and Stevens-Johnson syndromes]. Postovit VA; Khazak RS; Kunina TA Ter Arkh; 1976; 48(11):126-33. PubMed ID: 1021888 [No Abstract] [Full Text] [Related]
54. Ursodeoxycholic acid's role in avoiding diversionary surgery in idiopathic fibrosing pancreatitis. Rosenbaum J; Alex G; Clarnette T J Paediatr Child Health; 2009 Nov; 45(11):681-3. PubMed ID: 19845837 [TBL] [Abstract][Full Text] [Related]